JP2024102045A5 - - Google Patents
Info
- Publication number
- JP2024102045A5 JP2024102045A5 JP2024045217A JP2024045217A JP2024102045A5 JP 2024102045 A5 JP2024102045 A5 JP 2024102045A5 JP 2024045217 A JP2024045217 A JP 2024045217A JP 2024045217 A JP2024045217 A JP 2024045217A JP 2024102045 A5 JP2024102045 A5 JP 2024102045A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- gdc
- pharmaceutically acceptable
- administered
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063023501P | 2020-05-12 | 2020-05-12 | |
| US63/023,501 | 2020-05-12 | ||
| JP2022515505A JP2023500558A (ja) | 2020-05-12 | 2021-05-10 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
| PCT/US2021/031491 WO2021231250A1 (en) | 2020-05-12 | 2021-05-10 | Treatment of breast cancer using combination therapies comprising gdc-9545 and a cdk4/6 inhibitor |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022515505A Division JP2023500558A (ja) | 2020-05-12 | 2021-05-10 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024102045A JP2024102045A (ja) | 2024-07-30 |
| JP2024102045A5 true JP2024102045A5 (cg-RX-API-DMAC7.html) | 2025-12-16 |
Family
ID=76250442
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022515505A Withdrawn JP2023500558A (ja) | 2020-05-12 | 2021-05-10 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
| JP2023132463A Pending JP2023175688A (ja) | 2020-05-12 | 2023-08-16 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
| JP2024045217A Pending JP2024102045A (ja) | 2020-05-12 | 2024-03-21 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022515505A Withdrawn JP2023500558A (ja) | 2020-05-12 | 2021-05-10 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
| JP2023132463A Pending JP2023175688A (ja) | 2020-05-12 | 2023-08-16 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11918561B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4149476A1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2023500558A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230009390A (cg-RX-API-DMAC7.html) |
| CN (2) | CN115551513B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021272100B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3182018A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL298071A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022014133A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI800827B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021231250A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022222660A1 (en) * | 2021-02-16 | 2023-07-27 | Genentech, Inc. | Treatment of breast cancer using combination therapies comprising gdc-9545 and abemaciclib or ribociclib |
| KR20240163084A (ko) * | 2022-03-14 | 2024-11-18 | 제넨테크, 인크. | 유방암에 대한 복합 요법 |
| CN121337802B (zh) * | 2025-10-23 | 2026-04-14 | 安徽益普克医药科技发展有限公司 | 一种雌激素降解剂衍生物及其制备方法与用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105828822B (zh) * | 2013-08-14 | 2019-10-18 | 诺华股份有限公司 | 用于治疗癌症的组合疗法 |
| KR102358935B1 (ko) * | 2014-02-12 | 2022-02-04 | 가부시키가이샤 한도오따이 에네루기 켄큐쇼 | 전자 기기 |
| TWI874834B (zh) * | 2014-12-18 | 2025-03-01 | 瑞士商赫孚孟拉羅股份公司 | 四氫-吡啶并[3,4-b]吲哚雌激素受體調節劑及其用途 |
| KR20250152679A (ko) * | 2015-04-29 | 2025-10-23 | 래디어스 파마슈티컬스, 인코포레이티드 | 암을 치료하는 방법 |
| AU2017235450A1 (en) * | 2016-03-15 | 2018-08-16 | Merrimack Pharmaceuticals, Inc. | Methods for treating ER+, HER2-, HRG+ breast cancer using combination therapies comprising an anti-ErbB3 antibody |
| CR20200621A (es) * | 2018-06-21 | 2021-02-03 | Hoffmann La Roche | Formas sólidas de 3-((1r,3r)-1-(2,6-difluoro-4-((1-(3 fluoropropil)azetidin-3-il)amino)fenil)-3-(metil-1,3,4,9-tetrahidro-2h-pirido[3,4-b]indol-2-il)-2,2-difluoropropan-1-ol y procesos para preparar compuestos tricíclicos fusionados que comprenden un resto fenilo o piridinilo sustituido, incluidos métodos para su uso |
| JP7571006B2 (ja) | 2018-08-17 | 2024-10-22 | ジェネンテック， インコーポレイテッド | 乳がんの処置のための診断的および治療的方法 |
| JP7826068B2 (ja) * | 2022-03-11 | 2026-03-09 | 本田技研工業株式会社 | パワーユニット、及びパワーユニットを搭載した作業機 |
-
2021
- 2021-05-10 CN CN202180034978.8A patent/CN115551513B/zh active Active
- 2021-05-10 TW TW110116831A patent/TWI800827B/zh active
- 2021-05-10 IL IL298071A patent/IL298071A/en unknown
- 2021-05-10 CN CN202510482379.2A patent/CN120324434A/zh active Pending
- 2021-05-10 AU AU2021272100A patent/AU2021272100B2/en active Active
- 2021-05-10 KR KR1020227039518A patent/KR20230009390A/ko active Pending
- 2021-05-10 CA CA3182018A patent/CA3182018A1/en active Pending
- 2021-05-10 US US17/316,455 patent/US11918561B2/en active Active
- 2021-05-10 EP EP21729702.7A patent/EP4149476A1/en active Pending
- 2021-05-10 MX MX2022014133A patent/MX2022014133A/es unknown
- 2021-05-10 WO PCT/US2021/031491 patent/WO2021231250A1/en not_active Ceased
- 2021-05-10 JP JP2022515505A patent/JP2023500558A/ja not_active Withdrawn
-
2023
- 2023-08-16 JP JP2023132463A patent/JP2023175688A/ja active Pending
-
2024
- 2024-01-26 US US18/423,596 patent/US12303495B2/en active Active
- 2024-03-21 JP JP2024045217A patent/JP2024102045A/ja active Pending